Ambis 1973677 genscript customized biologicals

Ended Purchase Order Awarded Last action

Contract number
75N93019P01250
Awardee
Awarding agency
Obligated
$1,147,346

Award facts

Opportunity
Contract value 100% obligated
$1,147,346.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Piscataway, NJ 08854, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 -$46,876
Supplemental Agreement for work within scope P00003 -$192
Supplemental Agreement for work within scope P00002 · Genscript customized biologicals $0
Funding Only Action P00001 $69,144
Original award $1,125,270

About this award

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. valued at $1,147,346.00 on September 26, 2019, for customized biologicals under firm fixed pricing. Performance is located in Piscataway, New Jersey. The order has no small business set-aside and carried an ultimate completion date of September 25, 2020. The originating pre-solicitation was posted September 3, 2019, with a due date of September 6, 2019.

Quick answers

Who was awarded contract 75N93019P01250?

75N93019P01250 was awarded to Genscript USA Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 26, 2019.

How much is contract 75N93019P01250 worth?

The government has obligated $1,147,346 on 75N93019P01250.

Was contract 75N93019P01250 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award